ロード中...
Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer’s Disease
Alzheimer’s disease (AD) should be regarded as a degenerative metabolic disease caused by brain insulin resistance and deficiency, and overlapping with the molecular, biochemical, pathophysiological, and metabolic dysfunctions occurring in diabetes mellitus, non-alcoholic fatty liver disease, and me...
保存先:
| 出版年: | Drugs |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5575843/ https://ncbi.nlm.nih.gov/pubmed/27988872 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-016-0674-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|